Autopsy report · NCT03613090

Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue

“Withdrawn-was not approved by IRB”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of Alabama at Birmingham

Sponsor type

University, hospital or other

Conditions

Root Canal Therapy

Interventions

Collagen-hydroxyapatite scaffold (Syn-Oss); Collagen Scaffold (Colla-Plug)

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Impact of Cardiac Resynchronization Therapy on Right Ventricular Function in Left Ventricular Assist Device Patients
  “IRB Approval withdrawn” (91% match in meaning)
• Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.
  “Administratively withdrawn by the IRB prior to IRB approval” (88% match in meaning)
• Prospective Trial of Alerting to Extended Hypotensive Exposures on Long-Term Outcome After Surgery
  “IRB application withdrawn” (87% match in meaning)
• Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study
  “Study never initiated; withdrawn prior to receiving IRB approval” (83% match in meaning)
• Antibiotics and Tissue Expanders in Breast Reconstruction
  “The study was withdrawn prior to IRB approval.” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.